Skip to main content

Biomedlub (BML.WAR) Stock Price and Company Information, 2024

Biomedlub

BML.WAR

Exchange: WAR
Currency Polish złoty
ISIN: PLBMDLB00018
LEI: 259400OWZM67D079S374
Primary Ticker: BML.WAR
Fiscal Year End: December
Sector: Healthcare
Industry: Pharmaceuticals
Gic Sector: Health Care
Gic Group: Pharmaceuticals, Biotechnology & Life Sciences
Gic Industry: Pharmaceuticals
Gic Sub Industry: Pharmaceuticals
Description: Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50 and BCG 100 products for treating superficial (non-muscle invasive) bladder tumor; GAMMA anty H Bs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; Bio Trombina 400, a medication for topical control of severe bleeding; and Anti-Tuberculosis Vaccine BCG 10, a medication used in tuberculosis prevention. It also offers medical products comprising Ram blood for laboratory use; stonebrink medium for biovine Mycobacterium tuberculosis diagnostics; Löwenstein-Jensen medium with medicines for testing medicine susceptibility of Mycobacterium tuberculosis; Löwenstein-Jensen medium containing glycerolfor is used for identification of Mycobacterium tuberculosis; Ox Thrombin for in-vitro diagnostics and Lyophilisate; and rabbit plasma. In addition, the company provides reagents, such as horse serum, bovine serum, calf serum, trypsin, PBS fluid, hanks fluid, parker's fluid, Eagle 1959 medium, Rpmi 1640 medium, and Ogawa medium, as well as pseudo cholinesterase, Ox fibrinogen, and rabbit complements. The company was formerly known as BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. and changed its name to Synthaverse S.A. in July 2023. The company was founded in 1944 and is based in Lublin, Poland.
Address: Ul. Uniwersytecka 10, Lublin, Poland, 20-029
Website: https://biomedlublin.com
Full Time Employees: 234
Updated On: 2023-08-26

Highlights

Market Capitalization: 407510336
Market Capitalization Mln: 407.51
EBITDA: 17383000
PE Ratio: 52.72
Book Value: 1.51
Earnings Share: 0.11
Most Recent Quarter: 2023-03-31
Profit Margin: 0.13
Operating Margin TTM: 0.20
Return On Assets TTM: 0.04
Return On Equity TTM: 0.08
Revenue TTM: 53756000
Revenue Per Share TTM: 0.80
Quarterly Revenue Growth YOY: 0.39
Gross Profit TTM: 28467000
Diluted Eps TTM: 0.11
Quarterly Earnings Growth YOY: -0.18

Valuation

Trailing PE: 52.72
Price Sales TTM: 7.40
Price Book MRQ: 4.82
Enterprise Value: 398042368
Enterprise Value Revenue: 7.56
Enterprise Value Ebitda: 22.83

Technicals

Beta: 1.26
50 Day MA: 5.58
200 Day MA: 6.00

Earnings

Report Date: 2021-11-09
Date: 2021-09-30
Before After Market: After Market
Currency: PLN
Eps Actual: -0.00
Report Date: 2021-03-31
Date: 2021-03-31
Currency: PLN
Eps Actual: -0.01
Report Date: 2021-03-03
Date: 2020-12-31
Before After Market: After Market
Currency: PLN
Eps Actual: 0.05
Report Date: 2020-11-09
Date: 2020-09-30
Before After Market: After Market
Currency: PLN
Report Date: 2020-09-14
Date: 2020-06-30
Before After Market: After Market
Currency: PLN
Eps Actual: -0.00
Report Date: 2020-05-11
Date: 2020-03-31
Before After Market: After Market
Currency: PLN
Eps Actual: 0.01
Report Date: 2020-03-18
Date: 2019-12-31
Before After Market: Before Market
Currency: PLN
Eps Actual: 0.02
Report Date: 2019-09-30
Date: 2019-09-30
Currency: PLN
Report Date: 2019-06-30
Date: 2019-06-30
Currency: PLN
Report Date: 2019-03-31
Date: 2019-03-31
Currency: PLN
Report Date: 2018-12-31
Date: 2018-12-31
Currency: PLN
Eps Actual: -0.48
Report Date: 2018-09-30
Date: 2018-09-30
Currency: PLN
Eps Actual: -0.01
Report Date: 2018-06-30
Date: 2018-06-30
Currency: PLN
Eps Actual: -0.01
Report Date: 2018-03-31
Date: 2018-03-31
Currency: PLN
Eps Actual: -0.00
Report Date: 2017-12-31
Date: 2017-12-31
Currency: PLN
Eps Actual: 0.21
Report Date: 2017-09-30
Date: 2017-09-30
Currency: PLN
Report Date: 2017-06-30
Date: 2017-06-30
Currency: PLN
Eps Actual: -0.24
Report Date: 2017-03-31
Date: 2017-03-31
Currency: PLN
Eps Actual: -0.01
Report Date: 2016-12-31
Date: 2016-12-31
Currency: PLN
Eps Actual: -0.23
Report Date: 2016-09-30
Date: 2016-09-30
Currency: PLN
Eps Actual: -0.07
Report Date: 2016-06-30
Date: 2016-06-30
Currency: PLN
Eps Actual: -0.22
Report Date: 2016-03-31
Date: 2016-03-31
Currency: PLN
Report Date: 2015-12-31
Date: 2015-12-31
Currency: PLN
Eps Actual: -0.74
Report Date: 2015-09-30
Date: 2015-09-30
Currency: PLN
Eps Actual: -0.04
Report Date: 2015-06-30
Date: 2015-06-30
Currency: PLN
Eps Actual: -0.00
Report Date: 2015-03-31
Date: 2015-03-31
Currency: PLN
Eps Actual: -0.05
Report Date: 2014-12-31
Date: 2014-12-31
Currency: PLN
Eps Actual: 0.04
Report Date: 2014-09-30
Date: 2014-09-30
Currency: PLN
Eps Actual: -0.04
Report Date: 2014-06-30
Date: 2014-06-30
Currency: PLN
Eps Actual: -0.00
Report Date: 2014-03-31
Date: 2014-03-31
Currency: PLN
Report Date: 2013-12-31
Date: 2013-12-31
Currency: PLN
Eps Actual: 0.01
Report Date: 2013-09-30
Date: 2013-09-30
Currency: PLN
Eps Actual: 0.02
Report Date: 2013-06-30
Date: 2013-06-30
Currency: PLN
Report Date: 2013-03-31
Date: 2013-03-31
Currency: PLN
Eps Actual: 0.01
Report Date: 2012-12-31
Date: 2012-12-31
Currency: PLN
Eps Actual: -0.10
Report Date: 2012-09-30
Date: 2012-09-30
Currency: PLN
Eps Actual: -0.03
Report Date: 2012-06-30
Date: 2012-06-30
Currency: PLN
Eps Actual: -0.00
Report Date: 2012-03-31
Date: 2012-03-31
Currency: PLN
Date: 2021-09-30
Eps Actual: -0.02
Date: 2020-12-31
Eps Actual: 0.07
Date: 2019-12-31
Eps Actual: 0.03
Date: 2018-12-31
Eps Actual: -0.52
Date: 2017-12-31
Eps Actual: -0.04
Date: 2016-12-31
Eps Actual: -0.53
Date: 2015-12-31
Eps Actual: -0.84
Date: 2014-12-31
Date: 2013-12-31
Eps Actual: 0.06
Date: 2012-12-31
Eps Actual: -0.13